Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-1,3/1,6-D-Glucan in Non-infectious and Idiopathic Uveitis
NCT04162314Phase 3Unknown
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Jan 2020
- Primary completion
- Sep 2021
- Modality
- Polysaccharide, Dietary Supplement
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in uveitis comparing Beta-glucan + Methylprednisolone with Placebo + Methylprednisolone (2 arms). Primary endpoints: Change in anterior chamber inflammatory cells grading at 3 months and Change of serum TNF-alpha level at 3 months. Status: unknown.
02
Drugs
beta-1,3/1,6-d-glucan
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT04162314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04162314.